Monthly Archives: July 2019

Halitosis Keto Bad Breath Hotline Natural Health Teeth & Gums Treatment Released

Dentist formulated Breathealer recently released gives user’s fresh breath, reducing tooth sensitivity and treats Halitosis and Keto bad breath. Promoting healthy teeth and gums and producing a winning smile, Breathealer is an easy solution that delivers exceptional results.

Wilton Manors, United States – July 30, 2019 /NewsNetwork/

Fort Lauderdale, Florida-based Toothtapping Corp, an all-natural health company, has released their latest bad breath fixer Breathealer. Dentist formulated with healthy probiotics, Breathealer gives users fresh breath, helps reduce tooth sensitivity and treats Halitosis and Keto bad breath, so users gain a winning smile.

More information is available at https://breathealer.com

Recently released, Breathealer, which contains spearmint, peppermint and coconut oil, monk fruit extract, quillaja, methanol, vitamin E and palimate, comes in a convenient pump bottle for easy, comfortable use anywhere at any time day or night. With just two squirts on the tongue, this natural treatment freshens breath with a swill of the mouth and instantly refreshes the mouth packing a powerful punch when needed the most.

Ideal for the treatment of Halitosis and Keto bad breath, Breathealer is classified as the bad breath healer. This potent gel delivers a probiotic filled freshener to the areas of the mouth that need purification. Getting rid of harmful bacteria, Breathealer replaces the cause of bad breath with healthy, beneficial bacteria that improve overall wellbeing.

Easy to use on the go, Breathealer fits in a purse or pocket, making it a secret weapon on date nights, or when at working in close confinement with co-workers. Plus, each bottle contains 150 squirts, making this hard-hitting breath freshener an affordable solution for even those on the tightest of budgets.

When asked about Breathealer, a company representative said, “Celebrities like Kim Kardashian would most likely use an all-natural breath freshener like Breathealer to cure Halitosis or Keto bad breath. Regular use of this product also promotes good oral hygiene and improves health.”

To find out more about Breathealer, please click on the link above. Site visitors can also learn more about this powerful breath cleansing solution, how it promotes health and assists to cleanse the palate.

Contact Info:
Name: Dr Derek Golding
Email: Send Email
Organization: Toothtapping Corp
Address: 2319 N Andrews Avenue, Wilton Manors, Florida 33305, United States
Website: https://breathealer.com/

Source: NewsNetwork

Release ID: 88902260

Newborn Diaper Caddy Organizer Baby Shower Gift Accessory Carrier Launched

Arabella Baby has launched a new, upgraded high quality faux leather baby diaper organizer and caddy. The popular product is now even better, and makes an ideal gift for new moms or baby showers.

Boise, United States – July 30, 2019 /PressCable/

Arabella Baby has launched a new ultimate faux leather storage and organization caddy for moms looking to carry all their necessary baby items with ease. The new product features removable faux leather handles, corners, top and base, which makes it even more durable than their previous highly popular caddy.

More information can be found at: http://arabellababy.com

The design of the caddy has been acclaimed by customers because it allows moms and parents to have everything on hand when they need it. Parents can use the caddy in every room where they take care of their baby, and even use it with ease in the car.

This is important, because new parents have to carry around a large supply of equipment to look after their newborn. Whether they are in the home or out and about, they need quick and easy access to wipes, diapers, food, toys, soothers, and a range of other items.

Having these easily accessible can save vital seconds, ensuring parents can clean their baby when needed, change their diaper without hassle, and get easy access to snacks, milk or food to avoid a meltdown.

The site explains that for customers looking to buy a thoughtful baby shower gift or a present for new moms, it’s hard to think of a better option than something as useful as the Arabella Baby diaper bag organizer and caddy.

Arabella Baby states: “You’re going to be putting it on the ground a lot when you’re on the go. So instead of getting it dirty like other diaper bags, we added a Faux Leather Base – easy to wipe clean. Diaper bags take a few knocks too, so we added faux leather corners and top edging to this felt caddy.”

The company adds: “And unlike other caddies with fixed handles, we upgraded yours to removable Faux Leather clip handles so you could use it as a nursery storage bin. And the nicest thing, is they don’t get grubby after a week of carrying it around.”

Full details of the new product and its benefits can be found on the URL above.

Contact Info:
Name: RossAnne Gibson
Email: Send Email
Organization: Arabella Creations
Address: 8460 Golse Dr, Boise, Idaho 83704, United States
Website: http://www.arabellababy.com

Source: PressCable

Release ID: 88902162

CLASS ACTION UPDATE for ZUO, EROS and OMCL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / July 30, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Zuora, Inc. (NYSE:ZUO)

Lawsuit on behalf of: investors who purchased April 12, 2018 – May 30, 2019
Lead Plaintiff Deadline: August 13, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/zuora-inc-loss-form?prid=2682&wire=1

According to the filed complaint, during the class period, Zuora, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company would focus on implementing RevPro for new customers ahead of the deadline to comply with accounting standard ASC 606; (2) as a result, the Company lacked adequate resources to integrate RevPro with the core business; (3) the Company would focus on RevPro integration a year after the acquisition closed; (4) delays in integrating RevPro would materially impact the business; (5) the market for RevPro was limited to customers seeking to implement new accounting standards such as ASC 606; (6) after the deadline for ASC 606 compliance passed, demand for RevPro was reasonably likely to decline; and (7) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Eros International Plc (NYSE:EROS)

Lawsuit on behalf of: investors who purchased July 28, 2017 – June 5, 2019
Lead Plaintiff Deadline: August 20, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/eros-international-plc-loss-form?prid=2682&wire=1

According to the filed complaint, during the class period, Eros International Plc made materially false and/or misleading statements and/or failed to disclose that: (1) Eros and its executives engaged in a scheme to use related-party transactions to fabricate receivables that they reported in Eros’s public financial disclosures; (2) because of this scheme, Eros’s financial position was weaker than what the Company disclosed; (3) consequently, the Company’s Indian subsidiary, Eros International Media Ltd (“EIML”), missed loan payments and had its credit downgraded; and (4) due to the foregoing, Defendants’ statements about Eros’s receivables, business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Omnicell, Inc. (NASDAQGS:OMCL)

Lawsuit on behalf of: investors who purchased October 25, 2018 – July 11, 2019
Lead Plaintiff Deadline: September 16, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/omnicell-inc-loss-form?prid=2682&wire=1

According to the filed complaint, during the class period, Omnicell, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company recognized revenue for certain transactions before fulfilling its performance obligations; (2) the Company engaged in improper accounting practices to meet revenue targets; (3) the Company experienced weaker demand for new product lines than it had previously projected; (4) as a result, the Company would be required to write-off certain inventory; (5) the Company misclassified certain expenses as capitalized expenditures; and (6) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects and prospects were materially misleading and/or lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 554040

SHAREHOLDER ALERT: BUD DBD CTST: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / July 30, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Anheuser-Busch Inbev Sa/Nv (NYSE:BUD)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/anheuser-busch-inbev-sa-nv-loss-submission-form?prid=2681&wire=1
Lead Plaintiff Deadline: August 20, 2019
Class Period: March 1, 2018 to October 24, 2018

According to the filed complaint, Defendants issued a steady stream of materially false and misleading reassurances about Anheuser Busch’s deleveraging efforts, cost cutting measures, EBITDA growth, the sufficiency of its liquidity and its debt maturity profile during the Class Period. These positive statements by Defendants created a false impression and materially misled investors about the Company’s finances, including the sustainability of Anheuser-Busch’s dividends. Once Defendants chose to speak about Anheuser-Busch’s finances, they had a duty to speak completely and truthfully, including speaking about those factors that were then having a material adverse effect on the Company’s deleveraging efforts.

Diebold Nixdorf, Incorporated (NYSE:DBD)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/diebold-nixdorf-incorporated-loss-submission-form?prid=2681&wire=1
Lead Plaintiff Deadline: September 3, 2019
Class Period: February 14, 2017 to July 4, 2017

Allegations against DBD include that: (1) as a result of the Wincor acquisition and related integration, the Company was less focused on its core business; (2) the Company expected certain customers would not renew their service contracts (i.e. contract runoff); (3) the Company was not adequately prepared to staff service technicians; (4) as a result of the expected contract runoff, the Company would suffer a shortage of adequately trained service technicians; (5) as a result, the Company would suffer margin pressure in its services segment; (6) as a result of the foregoing, the Company would lose market share; and (7) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

CannTrust Holdings Inc. (NYSE:CTST)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/canntrust-holdings-inc-loss-submission-form?prid=2681&wire=1
Lead Plaintiff Deadline: September 9, 2019
Class Period: November 14, 2018 to July 12, 2019

According to filed complaints, CannTrust Holdings Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was growing cannabis in its Pelham greenhouse while applications for regulatory approval were still pending; (2) the Company’s Pelham greenhouse did not comply with certain regulations; (3) as a result, the Company was reasonably likely to face an inventory hold by Health Canada until the Pelham facility becomes compliant with applicable regulations; (4) as a result, the Company’s customers would face shortages and would likely seek product from CannTrust’s competitors; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 554039

AUGUST 6 ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Ascena Retail Group, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / July 30, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ascena Retail Group, Inc. (“Ascena” or “the Company”) (NASDAQ:ASNA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between September 16, 2015 and June 8, 2017, inclusive (the ”Class Period”), are encouraged to contact the firm before August 6, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Ascena’s acquisition of ANN, Inc. developed into a disaster for the Company based on ANN’s operations to be in far worse condition than was generally believed to be the case. The Company improperly delayed the recognition of an impairment charge related to ANN’s goodwill to mask the true extent of this problem. Based on this delay, the Company’s income and assets were overstated and its financial results were not in conformity with GAAP. Ascena overvalued many of the brands in the ANN acquisition as they were in serious decline. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Ascena, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com
Brian Schall, Esq.,
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 554038

DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Ra Medical Systems, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / July 30, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ra Medical Systems, Inc. (“Ra Medical” or “the Company”) (NYSE:RMED) for violations of the federal securities laws.

Investors who purchased the Company’s shares pursuant to and/or traceable to the Company’s Initial Public Offering in September 2018 (the “IPO”) are encouraged to contact the firm before August 6, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Ra Medical’s evaluation of sales candidates and training for those candidates hired were inadequate. The Company failed to ensure that candidates hired for sales positions had sufficient work experience. This resulted in the Company experiencing a shortage of qualified sales personnel. At the same time, the Company experienced problems in increasing catheter production, suffering production delays. Based on the facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Ra Medical, investors suffered damages.

Join the case to recover your losses. Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com
Brian Schall, Esq.,
Rina Restaino, Esq.,
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 554037

SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Oasmia Pharmaceutical AB and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / July 30, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Oasmia Pharmaceutical AB (“Oasmia” or “the Company”) (NASDAQ: OASM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between October 23, 2015 and July 9, 2019, inclusive (the ”Class Period”), are encouraged to contact the firm before September 27, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Oasmia engaged in deceptive and improper related-party transactions with Alceco International S.A. and Ardenia Investment LTD. These improper transactions resulted in millions of Swedish Kronor not accounted for in the Company’s books. Other transactions related to the Company’s patents were also “carried out in a doubtful way.” Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Oasmia, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 554036

BFA Announces Investigation of Capital One Data Breach Affecting 100 Million Individuals

OAKLAND, CA / ACCESSWIRE / July 30, 2019 / Bleichmar Fonti & Auld LLP is investigating Capital One Financial Corporation (NYSE: COF) following Capital One’s announcement of a data security breach affecting more than 100 million individuals and small businesses in the United States and Canada who applied for credit card products with the Company between 2005 and early 2019. The security breach includes credit card applications, names, addresses, credit scores, payment history, Social Security Numbers (U.S.) and Social Insurance Numbers (Canada), bank account numbers, partial transaction history, and other personally identifying information. The U.S. Department of Justice has filed a criminal complaint against an individual alleged to be responsible for the unauthorized taking of the information. This investigation is ongoing.

If you are or have been a Capital One customer, or applied for a credit card issued by Capital One between 2005 and 2019 and would like more information regarding your rights and this breach, please email krobertson@bfalaw.com.

SOURCE: Bleichmar, Fonti, & Auld LLP

ReleaseID: 554033

ONGOING INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Kingstone Companies, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / July 30, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Kingstone Companies, Inc. (“Kingstone” or “the Company”) (NASDAQ:KINS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between March 14, 2018 and April 29, 2019, inclusive (the ”Class Period”), are encouraged to contact the firm before August 12, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Kingstone failed to follow industry best practices on handling claims. The Company did not maintain appropriate claims reserves. The Company also lacked appropriate internal controls on financial reporting. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 554034

Discovery Gold Corporation (GRN Holding Corporation) Adds Peter Juvet to Its Strategic Advisory Board

SEATTLE, WA / ACCESSWIRE / July 30, 2019 / Discovery Gold Corporation. (OTC PINK:DCGD, the “Company”), which has announced a corporate name change to GRN Holding Corporation, is pleased to announce it has added retired sales executive Peter Juvet to its Strategic Advisory Board. In this capacity, Mr. Juvet is expected to assist the Company in its international and domestic sales and management structure.

Mr. Juvet was a sales executive for 3M, a Fortune 100 company for over 30 years. Mr. Juvet is a combat veteran of the Vietnam War and retired from the US Army as a Captain. Mr. Juvet was a Army Green Beret (special forces). He lives in the Issaquah, WA and dedicates his time to assist the Veterans Affairs (VA) as a volunteer and likes to race cars in his free time.

“Peter is a close friend and a patriot. It’s an honor to have a man of his caliber on our team, Pete is will bring a lot of value to the table” commented Justin Costello, CEO of the Company.

Regarding the appointment to the Advisory Board, Mr. Juvet said: “It’s exciting to see younger professionals like Mr. Costello and his team take new industries to the next level, I am energized to assist in designing DCGD’s top down management structure”

About Discovery Gold Corporation

Discovery Gold Corporation (OTC:DCGD) is a Nevada registered publicly traded company.

For more information, please contact:
Richard Hawkins
IR@grnholdingcorp.com

Forward-looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-k, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

SOURCE: Discovery Gold Corporation

ReleaseID: 554005